LabCorp to purchase Bio by year end

Discussion in 'Bio Reference' started by Anonymous, Sep 23, 2011 at 10:24 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Apparently was on Dark Daily and quickly removed. The rumor is they got LCA to pay 2.5X revenue. They much be desperate for market share to overpay that much.
     

  2. Anonymous

    Anonymous Guest

    No way!
     
  3. Anonymous

    Anonymous Guest

    No way Grodman will sell.
     
  4. Anonymous

    Anonymous Guest

    If it did happen that would be bad for CareEvolve!
     
  5. Anonymous

    Anonymous Guest

    Never going to happen. LabCorp looked at BIO a few years ago. They walked away. The reason is that BIO had so much bad debt, Grey Area billing etc, LabCorp felth there was to much liability.

    Genpath is a bundle of Medicare Fraud and LabCorp knows this.
     
  6. Anonymous

    Anonymous Guest

    OMG this is the same crap that gets posted on every other lab board. Here is the basic outline

    - Take a lab that isn't Quest or LabCorp
    - State lab is going to be purchased by Quest or LabCorp by end of year
    - Someone refutes because "Q or LCA has already looked at them and decided to not buy because of Medicare issues and bad billing"

    I am starting to think the same group of 3 or 4 idiot jump from board to board posting the same crap over and over and over again.
     
  7. Anonymous

    Anonymous Guest

    The idiots are those that are blind to the touch.
     
  8. anonymous

    anonymous Guest

    repost.... for the trolls that say the same thing.... it will never happen.
     
  9. anonymous

    anonymous Guest

    The Bio business unit for Opko is killing stock price as it is significantly underperforming.

    Without the ability to bill multiple flow units and hospital buyback deals, revenue is in a downward slide.

    Frost cannot afford to have a $5 stock price, so they will manage out all the waste and have the EPS better by QTR1 2018 or sell by QTR 2.

    That's what is being said by analysts.
     
  10. anonymous

    anonymous Guest

    Good! Poor DD to not realize the lab business is as a Rick Patino shoe contract.
     
  11. anonymous

    anonymous Guest

    Won’t happen.
     
  12. anonymous

    anonymous Guest

    Maybe not, but there is no doubt LC is all over the financials in the DD phase.
     
  13. anonymous

    anonymous Guest

    I have doubt. I’ve heard this crap for years.
     
  14. anonymous

    anonymous Guest

    Yeah - me too

    But pipeline management, no expense reports, mass layoffs, funky commissions, an overzealous compliance program????
     
  15. anonymous

    anonymous Guest

    well,,,,,it’s the end of the year........nothing!!! More fake news. Bio is not going anywhere.
     
  16. anonymous

    anonymous Guest

    It will happen in 2018
     
  17. anonymous

    anonymous Guest

    Hurry 12 hours left!!!!!!!!!
     
  18. anonymous

    anonymous Guest

    Very quiet forum considering that Bio might be bought real soon.
     
  19. anonymous

    anonymous Guest

    I would rephrase that to purchased for assets and then dissolved.
     
  20. anonymous

    anonymous Guest

    Not Lab Corp, the other lab,,,,, Lenco is the one!!